Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Proportion of SARS-CoV-2 Infections That Are Asymptomatic
Daniel P. Oran, Eric J. Topol
Annals of Internal Medicine (2021) Vol. 174, Iss. 5, pp. 655-662
Open Access | Times Cited: 521

Showing 1-25 of 521 citing articles:

Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection
Aravind Natarajan, Soumaya Zlitni, Erin F. Brooks, et al.
Med (2022) Vol. 3, Iss. 6, pp. 371-387.e9
Open Access | Times Cited: 329
Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Yanjia Chen, Xiaoyu Zhao, Hao Zhou, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 189-199
Open Access | Times Cited: 272
Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation
Brit Long, Brandon M Carius, Summer Chavez, et al.
The American Journal of Emergency Medicine (2022) Vol. 54, pp. 46-57
Open Access | Times Cited: 220
Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer
Suresh V. Kuchipudi, Meera Surendran Nair, Rachel M. Ruden, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 6
Open Access | Times Cited: 207
Long COVID and its Management
Ho Cheng Koc, Jing Xiao, Weiwei Liu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4768-4780
Open Access | Times Cited: 202
Global Financial Crisis, Smart Lockdown Strategies, and the COVID-19 Spillover Impacts: A Global Perspective Implications From Southeast Asia
Chunlei Wang, Dake Wang, Jaffar Abbas, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 194
CT of Post-Acute Lung Complications of COVID-19
Joshua J. Solomon, B. Heyman, Jane P. Ko, et al.
Radiology (2021) Vol. 301, Iss. 2, pp. E383-E395
Open Access | Times Cited: 176
COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection
Kevin Escandón-Vargas, Angela L. Rasmussen, Isaac I. Bogoch, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 165
Ivermectin for preventing and treating COVID-19
Maria Popp, Stefanie Reis, Selina Schießer, et al.
Cochrane library (2022) Vol. 2024, Iss. 3
Open Access | Times Cited: 154
Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan
Kento Kuzuu, Noboru Misawa, Keiichi Ashikari, et al.
JAMA Network Open (2021) Vol. 4, Iss. 9, pp. e2126334-e2126334
Open Access | Times Cited: 118
Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis
Weijing Shang, Liangyu Kang, Guiying Cao, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1049-1049
Open Access | Times Cited: 114
Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19
Giovanna S. Manzano, Caleb R.S. McEntire, Maria Martinez‐Lage, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 8, Iss. 6
Open Access | Times Cited: 110
Prevalence, clinical characteristics and outcomes of Guillain−Barré syndrome spectrum associated with COVID‐19: A systematic review and meta‐analysis
Lina Palaiodimou, Maria‐Ioanna Stefanou, Aristeidis H. Katsanos, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 10, pp. 3517-3529
Open Access | Times Cited: 107
A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part
Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 10
Open Access | Times Cited: 100
A wastewater-based epidemic model for SARS-CoV-2 with application to three Canadian cities
Shokoofeh Nourbakhsh, Aamir Fazil, Michael Li, et al.
Epidemics (2022) Vol. 39, pp. 100560-100560
Open Access | Times Cited: 91
Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine
Nabin K. Shrestha, Patrick C. Burke, Amy S. Nowacki, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 6
Open Access | Times Cited: 79
SARS-CoV-2 and the Host Cell: A Tale of Interactions
Massimo Pizzato, Chiara Baraldi, Giulia Boscato Sopetto, et al.
Frontiers in Virology (2022) Vol. 1
Open Access | Times Cited: 69
Global SARS-CoV-2 genomic surveillance: What we have learned (so far)
Stephane Tosta, Keldenn Melo Farias Moreno, Gabriel Schuab, et al.
Infection Genetics and Evolution (2023) Vol. 108, pp. 105405-105405
Open Access | Times Cited: 54
Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond
Michael D. Parkins, Bonita E. Lee, Nicole Acosta, et al.
Clinical Microbiology Reviews (2023) Vol. 37, Iss. 1
Closed Access | Times Cited: 46
Masks and respirators for prevention of respiratory infections: a state of the science review
Trisha Greenhalgh, C. Raina MacIntyre, Michael G. Baker, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Open Access | Times Cited: 23
Autoantibodies in COVID-19: implications for disease severity and clinical outcomes
Yannick Galipeau, Curtis Cooper, Marc‐André Langlois
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Ivermectin for preventing and treating COVID-19
Maria Popp, Miriam Stegemann, Maria‐Inti Metzendorf, et al.
Cochrane library (2021) Vol. 2021, Iss. 10
Open Access | Times Cited: 89
The success of SARS-CoV-2 vaccines and challenges ahead
Kanta Subbarao
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1111-1123
Open Access | Times Cited: 87
Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role
Samson Mathews Samuel, Elizabeth Varghese, Dietrich Büsselberg
Trends in Microbiology (2021) Vol. 29, Iss. 10, pp. 894-907
Open Access | Times Cited: 81
Averting an Outbreak of SARS-CoV-2 in a University Residence Hall through Wastewater Surveillance
Ryland Corchis-Scott, Qiudi Geng, Rajesh Seth, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 74
Page 1 - Next Page

Scroll to top